Saturday, June 24, 2017 10:18:43 AM
The word is spreading our fate is now in our hands and there is so much momentum that I'm ever more confident in a blockbuster platform & just Afrezza alone making this a multi-billion $ company.
Friday morning trading was based on great numbers and the late afternoon was all rebalancing with the Russell. The stock price in AH's was $1.56 and I'm confident we see news next week along with a $1.70-$1.90 move or higher. I'm guessing Mike C didn't release news last week because it made sense to wait until rebalancing was completed associated with the Russell.
The Russell 2000 will have MNKD in it next year, so market my words on that one. I've seen stocks double overnight just on the announcement of insurance coverage from a major insurer. We have Aetna, Cigna, many BC/BS, Express Scripts, VA and I'm sure others that still have not been formally announced. The UAE is not a rumor, but the real deal and that news will be forthcoming as well.
Really looking forward to the next few months and now that the Reg Short list hit 23 days there is no way that can be ignored much longer. Monday we will gain some real nice traction and get back to those Friday morning highs we saw before the rebalancing.
The launch of the Mattocks show, commercials, and much more in July will finally put Afrezza on the map. I'm sure social media will kick in as well. Remember 99% of all diabetics don't know about the product and its just recently that Endo's and physicians started to become aware of this game changing drug. I said end of summer before it all kicks in and IMO we are now a head of schedule.
Deerfield will be resolved and not even a problem as they aren't going to walk away at this point or cause some absurd financing to take place. Hell the stock is up 50% from where they did the last conversion, so why won't they agree to work something else out? I'm so excited I can't wait for next week to get here already. Mahalo and have a great weekend.
Recent MNKD News
- MannKind Repays Certain Debt Obligations • GlobeNewswire Inc. • 04/03/2024 10:00:00 AM
- MannKind Announces CFO Transition • GlobeNewswire Inc. • 03/26/2024 08:05:00 PM
- INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin Pumps • GlobeNewswire Inc. • 03/11/2024 10:05:00 AM
- MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8 • GlobeNewswire Inc. • 03/05/2024 11:05:00 AM
- MannKind Corporation Announces Participation at Upcoming Conferences • GlobeNewswire Inc. • 03/04/2024 06:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:20 PM
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update • GlobeNewswire Inc. • 02/27/2024 09:00:00 PM
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 11:00:00 AM
- MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza® • GlobeNewswire Inc. • 02/15/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:31 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:12 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 11:06:28 AM
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million • GlobeNewswire Inc. • 01/02/2024 11:05:00 AM
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/28/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:15:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2023 02:00:12 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2023 09:09:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/15/2023 12:56:53 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/14/2023 09:08:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:05:18 PM
- MannKind Corporation Reports 2023 Third Quarter Financial Results • GlobeNewswire Inc. • 11/07/2023 09:00:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM